Document is current
Any future updates will be listed below
-
Authors
Pausch, Patrick
Soczek, Katarzyna M. http://orcid.org/0000-0003-3803-6079
Herbst, Dominik A. http://orcid.org/0000-0003-4671-5493
Tsuchida, Connor A.
Al-Shayeb, Basem
Banfield, Jillian F.
Nogales, Eva http://orcid.org/0000-0001-9816-3681
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
- License Information
-
More Information
Article History
Received: 6 April 2021
Accepted: 24 June 2021
First Online: 11 August 2021
Competing interests
: The Regents of the University of California, Berkeley have patents pending for CRISPR technologies on which the authors are inventors. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Algen Biotechnologies, Felix Biosciences, The Column Group and Inari. J.A.D. is a director at Johnson & Johnson and Tempus and has research projects sponsored by Biogen, Pfizer, AppleTree Partners and Roche. J.F.B. is a founder of Metagenomi. The remaining authors declare no competing interests.
